Skip to main content

U.S. Pharmaceutical Sales - Q2 2013

The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q2 2013 by Units Sold

Rank Drug Units (000)
1 budesonide
Generic
-18.72% Stats
2 acetaminophen/hydrocodone
Generic
-4.30% Stats
3 omeprazole
Generic
-7.34% Stats
4 ProAir HFA
Teva Pharmaceuticals USA, Inc.
4.92% Stats
5 (2) atorvastatin
Generic
9.77% Stats
6 Cymbalta
2.77% Stats
7 (2) Nexium
AstraZeneca
-8.43% Stats
8 OneTouch
-1.87% Stats
9 (1) Advair Diskus
GlaxoSmithKline
-5.22% Stats
10 (1) Lantus
Sanofi
-4.32% Stats
11 (2) Ventolin HFA
GlaxoSmithKline
-11.55% Stats
12 Lantus Solostar
Sanofi
1.01% Stats
13 enoxaparin
Generic
-0.37% Stats
14 (1) Crestor
AstraZeneca
-0.83% Stats
15 (1) fentanyl
Generic
-6.38% Stats
16 (1) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
0.89% Stats
17 (1) Levemir
Novo Nordisk
4.69% Stats
18 (2) NovoLog FlexPen
Novo Nordisk
3.49% Stats
19 Novolog
Novo Nordisk
-2.14% Stats
20 (1) metoprolol
Generic
4.10% Stats
21 (1) Humalog
Eli Lilly and Company
-0.66% Stats
22 (1) Nasonex
Merck
n/a Stats
23 (1) Synthroid
AbbVie Inc.
4.19% Stats
24 (1) Abilify
Otsuka Pharmaceutical Co., Ltd
1.17% Stats
25 (1) Januvia
Merck
0.04% Stats
26 (1) Symbicort
AstraZeneca
4.12% Stats
27 (1) Lyrica
Pfizer Inc.
3.09% Stats
28 (3) Zetia
Merck
-0.30% Stats
29 (1) Namenda
Allergan plc
-2.73% Stats
30 (2) Diovan
Novartis Pharmaceuticals Corporation
-2.29% Stats
31 (2) Suboxone
-13.60% Stats
32 (1) Flovent HFA
GlaxoSmithKline
-7.50% Stats
33 (3) Lidoderm
Endo Pharmaceuticals Inc.
1.88% Stats
34 (1) AndroGel
AbbVie Inc.
-2.79% Stats
35 (3) Remicade
Janssen Pharmaceuticals, Inc.
1.19% Stats
36 (1) fenofibrate
Generic
-1.92% Stats
37 (2) Lovaza
GlaxoSmithKline
-1.72% Stats
38 (4) Restasis
Allergan plc
1.74% Stats
39 (1) Benicar
Daiichi Sankyo
-0.33% Stats
40 (1) Dexilant
Takeda Pharmaceutical Company Limited
-0.60% Stats
41 (4) Humalog KwikPen
Eli Lilly and Company
-0.09% Stats
42 (1) OxyContin
Purdue Pharma LP
-5.87% Stats
43 (3) VESIcare
Astellas Pharma US, Inc.
-2.75% Stats
44 (4) Celebrex
Pfizer Inc.
2.28% Stats
45 (6) Enbrel
Amgen Inc.
4.33% Stats
46 (1) Vytorin
Merck
-6.64% Stats
47 (2) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
-2.75% Stats
48 (2) Janumet
Merck
-1.75% Stats
49 (7) Cialis
Eli Lilly and Company
3.95% Stats
50 (3) Evista
-3.30% Stats
51 (1) Niaspan
AbbVie Inc.
-7.65% Stats
52 () Xarelto
n/a Stats
53 (1) doxycycline
Generic
-2.24% Stats
54 (3) methylphenidate
Generic
-6.30% Stats
55 (3) Vyvanse
Takeda Pharmaceutical Company Limited
-7.49% Stats
56 (3) amphetamine/dextroamphetamine
Generic
-2.49% Stats
57 (4) Humira
AbbVie Inc.
9.83% Stats
58 (4) Victoza
Novo Nordisk
2.14% Stats
59 (4) Epogen
Amgen Inc.
3.39% Stats
60 Aciphex
Eisai Inc.
-10.58% Stats
61 (4) Rituxan
Genentech, Inc.
1.96% Stats
62 (4) Truvada
Gilead Sciences, Inc.
1.82% Stats
63 (1) Rebif
EMD Serono, Inc.
-6.41% Stats
64 (4) Avastin
Genentech, Inc.
2.60% Stats
65 (2) Atripla
Gilead Sciences, Inc.
-2.92% Stats
66 (3) Viagra
Pfizer Inc.
-1.58% Stats
67 (4) modafinil
Generic
12.13% Stats
68 (2) Seroquel XR
AstraZeneca
-0.99% Stats
69 (7) Orencia
Bristol-Myers Squibb Company
5.23% Stats
70 (2) Renvela
Sanofi
-4.80% Stats
71 (2) Lunesta
Sunovion Pharmaceuticals Inc.
-3.57% Stats
72 (2) Neulasta
Amgen Inc.
-1.82% Stats
73 (4) Sensipar
Amgen Inc.
3.24% Stats
74 (5) Xolair
7.97% Stats
75 Adderall XR
Takeda Pharmaceutical Company Limited
-8.90% Stats
76 (4) Procrit
Janssen Pharmaceuticals, Inc.
4.81% Stats
77 (4) Isentress
Merck
1.49% Stats
78 (6) Prezista
Janssen Pharmaceuticals, Inc.
8.98% Stats
79 (6) Lucentis
Genentech, Inc.
10.33% Stats
80 (2) Reyataz
Bristol-Myers Squibb Company
-0.38% Stats
81 (2) Aranesp
Amgen Inc.
-2.43% Stats
82 (5) Copaxone
Teva Pharmaceuticals USA, Inc.
-0.44% Stats
83 (5) Alimta
Eli Lilly and Company
11.73% Stats
84 (5) Herceptin
Genentech, Inc.
-0.60% Stats
85 (5) Neupogen
Amgen Inc.
0.61% Stats
86 (5) Prevnar 13
Pfizer Inc.
6.49% Stats
87 () Invega Sustenna
Janssen Pharmaceuticals, Inc.
n/a Stats
88 (4) Zyvox
Pfizer Inc.
-9.86% Stats
89 (4) Xgeva
Amgen Inc.
4.10% Stats
90 (4) Avonex
Biogen
-9.28% Stats
91 (4) Gleevec
Novartis Pharmaceuticals Corporation
7.32% Stats
92 (5) Betaseron
Bayer HealthCare Pharmaceuticals Inc.
52.63% Stats
93 () Sandostatin LAR Depot
Novartis Pharmaceuticals Corporation
n/a Stats
94 (2) Xeloda
Genentech, Inc.
6.78% Stats
95 (3) Gilenya
Novartis Pharmaceuticals Corporation
10.71% Stats
96 (2) Avonex Pen
Biogen
-46.39% Stats
97 () Zytiga
Janssen Pharmaceuticals, Inc.
n/a Stats
98 (1) Stelara
Janssen Pharmaceuticals, Inc.
8.33% Stats
99 () Afinitor
Novartis Pharmaceuticals Corporation
n/a Stats
100 Incivek
Vertex Pharmaceuticals Incorporated
-21.43% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.